{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Nilotinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Nilotinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Nilotinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "nilotinib",
    "trial_2_text": "Nilotinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Nilotinib Supplement: 60 participants will take Nilotinib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Nilotinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Nilotinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.3570963442325592,
      "123": 0.2824874520301819,
      "64": 0.26051273941993713,
      "78": 0.22420483827590942,
      "189": 0.22068898379802704,
      "20": 0.19664086401462555,
      "21": 0.19452150166034698,
      "188": 0.186878964304924,
      "228": 0.17979146540164948,
      "49": 0.17053915560245514,
      "173": 0.16207751631736755,
      "177": 0.148224338889122,
      "17": 0.1466764658689499,
      "67": 0.1457044780254364,
      "68": 0.143581360578537,
      "191": 0.13068409264087677,
      "29": 0.12910209596157074,
      "46": 0.1285046637058258,
      "9": 0.126959890127182,
      "101": 0.12494706362485886,
      "136": 0.12260504812002182,
      "200": 0.1151118054986,
      "179": 0.11113560944795609,
      "2": 0.10849230736494064,
      "126": 0.1067831814289093,
      "14": 0.10648920387029648,
      "114": 0.10158953815698624,
      "37": 0.09887199848890305,
      "350": 0.09870823472738266,
      "261": 0.09362848103046417,
      "193": 0.09207863360643387,
      "27": 0.09196265041828156,
      "121": 0.09143649786710739,
      "211": 0.08729821443557739,
      "257": 0.08665261417627335,
      "61": 0.086326465010643,
      "76": 0.0854688510298729,
      "243": 0.08507378399372101,
      "28": 0.08479508012533188,
      "142": 0.0844833180308342,
      "77": 0.08177869021892548,
      "194": 0.08138798177242279,
      "147": 0.08123239874839783,
      "151": 0.08054234832525253,
      "104": 0.07806389033794403,
      "85": 0.07553680986166,
      "79": 0.07513786107301712,
      "253": 0.07412707060575485,
      "282": 0.07378515601158142,
      "239": 0.07358752191066742,
      "356": 0.07308566570281982,
      "288": 0.0722058117389679,
      "249": 0.07059002667665482,
      "18": 0.0702781155705452,
      "343": 0.06696280837059021,
      "355": 0.06654542684555054,
      "96": 0.06631962209939957,
      "5": 0.06554964184761047,
      "269": 0.06543084979057312,
      "35": 0.06532835960388184,
      "396": 0.06497000902891159,
      "186": 0.06464885920286179,
      "130": 0.06399688869714737,
      "180": 0.06339891254901886,
      "131": 0.06252270191907883,
      "341": 0.062184952199459076,
      "154": 0.06217751279473305,
      "33": 0.06180915609002113,
      "30": 0.061637215316295624,
      "82": 0.06159637123346329,
      "122": 0.06043865531682968,
      "86": 0.05975397303700447,
      "72": 0.05828973278403282,
      "213": 0.05760513246059418,
      "31": 0.057175204157829285,
      "38": 0.05623213201761246,
      "212": 0.0556056909263134,
      "382": 0.05447204038500786,
      "102": 0.05409763753414154,
      "441": 0.053146738559007645,
      "276": 0.05215742439031601,
      "246": 0.05199042335152626,
      "286": 0.049931202083826065,
      "347": 0.048563335090875626,
      "22": 0.047738708555698395,
      "116": 0.04734158515930176,
      "255": 0.046867627650499344,
      "164": 0.046730171889066696,
      "371": 0.04627618566155434,
      "36": 0.045682165771722794,
      "100": 0.04490669444203377,
      "466": 0.04453684389591217,
      "144": 0.044213246554136276,
      "4": 0.04378150403499603,
      "124": 0.043762750923633575,
      "422": 0.04351329058408737,
      "263": 0.042869891971349716,
      "139": 0.042778097093105316,
      "99": 0.04251919314265251,
      "361": 0.04204029217362404
    },
    "trial_2_ae": {
      "87": 0.3570963442325592,
      "123": 0.2824874520301819,
      "64": 0.26051273941993713,
      "78": 0.22420483827590942,
      "189": 0.22068898379802704,
      "20": 0.19664086401462555,
      "21": 0.19452150166034698,
      "188": 0.186878964304924,
      "228": 0.17979146540164948,
      "49": 0.17053915560245514,
      "173": 0.16207751631736755,
      "177": 0.148224338889122,
      "17": 0.1466764658689499,
      "67": 0.1457044780254364,
      "68": 0.143581360578537,
      "191": 0.13068409264087677,
      "29": 0.12910209596157074,
      "46": 0.1285046637058258,
      "9": 0.126959890127182,
      "101": 0.12494706362485886,
      "136": 0.12260504812002182,
      "200": 0.1151118054986,
      "179": 0.11113560944795609,
      "2": 0.10849230736494064,
      "126": 0.1067831814289093,
      "14": 0.10648920387029648,
      "114": 0.10158953815698624,
      "37": 0.09887199848890305,
      "350": 0.09870823472738266,
      "261": 0.09362848103046417,
      "193": 0.09207863360643387,
      "27": 0.09196265041828156,
      "121": 0.09143649786710739,
      "211": 0.08729821443557739,
      "257": 0.08665261417627335,
      "61": 0.086326465010643,
      "76": 0.0854688510298729,
      "243": 0.08507378399372101,
      "28": 0.08479508012533188,
      "142": 0.0844833180308342,
      "77": 0.08177869021892548,
      "194": 0.08138798177242279,
      "147": 0.08123239874839783,
      "151": 0.08054234832525253,
      "104": 0.07806389033794403,
      "85": 0.07553680986166,
      "79": 0.07513786107301712,
      "253": 0.07412707060575485,
      "282": 0.07378515601158142,
      "239": 0.07358752191066742,
      "356": 0.07308566570281982,
      "288": 0.0722058117389679,
      "249": 0.07059002667665482,
      "18": 0.0702781155705452,
      "343": 0.06696280837059021,
      "355": 0.06654542684555054,
      "96": 0.06631962209939957,
      "5": 0.06554964184761047,
      "269": 0.06543084979057312,
      "35": 0.06532835960388184,
      "396": 0.06497000902891159,
      "186": 0.06464885920286179,
      "130": 0.06399688869714737,
      "180": 0.06339891254901886,
      "131": 0.06252270191907883,
      "341": 0.062184952199459076,
      "154": 0.06217751279473305,
      "33": 0.06180915609002113,
      "30": 0.061637215316295624,
      "82": 0.06159637123346329,
      "122": 0.06043865531682968,
      "86": 0.05975397303700447,
      "72": 0.05828973278403282,
      "213": 0.05760513246059418,
      "31": 0.057175204157829285,
      "38": 0.05623213201761246,
      "212": 0.0556056909263134,
      "382": 0.05447204038500786,
      "102": 0.05409763753414154,
      "441": 0.053146738559007645,
      "276": 0.05215742439031601,
      "246": 0.05199042335152626,
      "286": 0.049931202083826065,
      "347": 0.048563335090875626,
      "22": 0.047738708555698395,
      "116": 0.04734158515930176,
      "255": 0.046867627650499344,
      "164": 0.046730171889066696,
      "371": 0.04627618566155434,
      "36": 0.045682165771722794,
      "100": 0.04490669444203377,
      "466": 0.04453684389591217,
      "144": 0.044213246554136276,
      "4": 0.04378150403499603,
      "124": 0.043762750923633575,
      "422": 0.04351329058408737,
      "263": 0.042869891971349716,
      "139": 0.042778097093105316,
      "99": 0.04251919314265251,
      "361": 0.04204029217362404
    }
  },
  "safety": {
    "trial_1_safety": 0.4970758259296417,
    "trial_2_safety": 0.4970758259296417
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47469398379325867
  }
}